Grant: Discovery Grants Program - Individual
University of Toronto
$72,000.00
The regulation of brain docosahexaenoic acid turnover.
FY 2024-25
Summary
Brain phospholipids are relatively enriched with docosahexaenoic acid (DHA; 22:6n-3), where it can be released by activation of phospholipase A2 and either re-esterified or metabolised into a series of mediators including oxylipins, and ethanolamides. Within the brain DHA, either directly or upon conversion into various bioactive metabolites, act as secondary messengers in response to neurotransmission and other signals which regulate a variety of functions including cell survival, inflammation, and memory. We have recently developed a new method by which we can study brain DHA turnover, as a proxy for brain DHA uptake and consumption, that integrates whole body physiology. In this model, we combine gas chromatography combustion high-precision isotope ratio combustion mass spectrometry (GCcIRMS) which allows us to differentiate DHA obtained from different sources. By taking serial samples upon switching the source of DHA in the diet we can measure the turnover in tissues which can be independent of changes in brain DHA concentrations. In this proposal we aim to study factors thought to regulated brain DHA uptake directly or indirectly. Mores specifically, we aim to study (1) how the dose of DHA and (2) different dietary sources of DHA (triacylglycerides and lysophospholipid) regulate brain DHA turnover. The first aim will be important in setting foundations for future studies while the second will help resolve a controversy in the field. We then aim to test how candidate proteins involved in DHA uptake (aim 3 acyl-CoA synthetase and aim 4 Mfsd2a) regulate brain DHA turnover before testing if stress models known to effect DHA metabolism (aim 5 ethanol consumption and aim 6 obesity) can regulate brain DHA turnover. Methods: In order to measure the small, but precise differences in carbon 13, we use high-precision GCcIRMS. By switching the source of DHA from either a relatively high carbon 13 low or vice-versa, we can measure tissue turnover. Thus, prior to the experimental manipulation, mice will consume either a low or high carbon 13 source of DHA which contrasts the experimental manipulation so we can measure the turnover. The primary outcome of these studies will be brain DHA turnover; however, our method also extends to other tissues allowing us a whole-body integrative model that will provide mechanistic support/insight for any changes in brain DHA metabolism. Tissues with altered DHA turnover will then be subjected to more detailed lipidomic and transcriptomic analysis to identify candidate pathways by which DHA is consumed as well as candidate genes related to in the mechanism of action. Furthermore, we will study DHA turnover in both male and female mice. Results from this NSERC discovery grant will not only further elucidate the mechanisms that regulate brain DHA turnover but will provide a method that could be adapted to further the study of other fatty acids, lipids and molecules.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2024-05854
Name nom
Bazinet, Richard
Department département
Nutritional Sciences
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
72000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5405
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Lipids
Research subject fr
Lipides
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
The regulation of brain docosahexaenoic acid turnover.
Keywords
brain; fatty acid; docosahexaenoic acid; turnover; nutrition; phospholipid; diet; mouse
Application summary
Brain phospholipids are relatively enriched with docosahexaenoic acid (DHA; 22:6n-3), where it can be released by activation of phospholipase A2 and either re-esterified or metabolised into a series of mediators including oxylipins, and ethanolamides. Within the brain DHA, either directly or upon conversion into various bioactive metabolites, act as secondary messengers in response to neurotransmission and other signals which regulate a variety of functions including cell survival, inflammation, and memory. We have recently developed a new method by which we can study brain DHA turnover, as a proxy for brain DHA uptake and consumption, that integrates whole body physiology. In this model, we combine gas chromatography combustion high-precision isotope ratio combustion mass spectrometry (GCcIRMS) which allows us to differentiate DHA obtained from different sources. By taking serial samples upon switching the source of DHA in the diet we can measure the turnover in tissues which can be independent of changes in brain DHA concentrations. In this proposal we aim to study factors thought to regulated brain DHA uptake directly or indirectly. Mores specifically, we aim to study (1) how the dose of DHA and (2) different dietary sources of DHA (triacylglycerides and lysophospholipid) regulate brain DHA turnover. The first aim will be important in setting foundations for future studies while the second will help resolve a controversy in the field. We then aim to test how candidate proteins involved in DHA uptake (aim 3 acyl-CoA synthetase and aim 4 Mfsd2a) regulate brain DHA turnover before testing if stress models known to effect DHA metabolism (aim 5 ethanol consumption and aim 6 obesity) can regulate brain DHA turnover. Methods: In order to measure the small, but precise differences in carbon 13, we use high-precision GCcIRMS. By switching the source of DHA from either a relatively high carbon 13 low or vice-versa, we can measure tissue turnover. Thus, prior to the experimental manipulation, mice will consume either a low or high carbon 13 source of DHA which contrasts the experimental manipulation so we can measure the turnover. The primary outcome of these studies will be brain DHA turnover; however, our method also extends to other tissues allowing us a whole-body integrative model that will provide mechanistic support/insight for any changes in brain DHA metabolism. Tissues with altered DHA turnover will then be subjected to more detailed lipidomic and transcriptomic analysis to identify candidate pathways by which DHA is consumed as well as candidate genes related to in the mechanism of action. Furthermore, we will study DHA turnover in both male and female mice. Results from this NSERC discovery grant will not only further elucidate the mechanisms that regulate brain DHA turnover but will provide a method that could be adapted to further the study of other fatty acids, lipids and molecules.